Professor of Medicine
New York University School of Medicine
New York University School of Medicine
New York, New York, United States
Dr. Bangalore is an interventional cardiologist and a tenured professor of medicine at New York University School of Medicine. He is the Director of Invasive and Interventional Cardiology, Interventional Director for Adult ECMO and MCS Program, Bellevue Hospital; and Director of Research for the cardiac catheterization laboratory at NYU Langone Health. His research interests are in comparative effectiveness studies for cardiovascular diseases, particularly stable ischemic heart disease, acute coronary syndromes, hypertension and dyslipidemia. Dr. Bangalore has received grants from the National Institutes of Health, Agency for Healthcare Research and Quality, American Heart Association and from the industry. He has published over 500 articles in leading national and international journals including the NEJM, JAMA, JAMA cardiology, Lancet, Circulation and JACC.
Saturday, February 25, 2023
3:15 PM – 3:23 PM ET
Disclosure(s): Abbott Vascular: Consultant/Advisory Board (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Terminated); Merck Pharmaceuticals: Consultant/Advisory Board (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing)
Saturday, February 25, 2023
4:30 PM – 5:30 PM ET
Disclosure(s): Abbott Vascular: Consultant/Advisory Board (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Terminated); Merck Pharmaceuticals: Consultant/Advisory Board (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing)
Sunday, February 26, 2023
9:45 AM – 9:55 AM ET
Disclosure information not submitted.
Sunday, February 26, 2023
8:00 AM – 9:35 AM ET
Disclosure(s): Abbott Vascular: Consultant/Advisory Board (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Terminated); Merck Pharmaceuticals: Consultant/Advisory Board (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing)
Sunday, February 26, 2023
9:04 AM – 9:35 AM ET
Disclosure(s): Abbott Vascular: Consultant/Advisory Board (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Terminated); Merck Pharmaceuticals: Consultant/Advisory Board (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing)
Sunday, February 26, 2023
10:15 AM – 10:30 AM ET
Disclosure(s): Abbott Vascular: Consultant/Advisory Board (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Terminated); Merck Pharmaceuticals: Consultant/Advisory Board (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing)
Sunday, February 26, 2023
11:42 AM – 11:50 AM ET
Disclosure(s): Abbott Vascular: Consultant/Advisory Board (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Terminated); Merck Pharmaceuticals: Consultant/Advisory Board (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing)
Monday, February 27, 2023
12:30 PM – 12:40 PM ET
Disclosure information not submitted.
Monday, February 27, 2023
7:24 AM – 7:32 AM ET
Disclosure(s): Abbott Vascular: Consultant/Advisory Board (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Terminated); Merck Pharmaceuticals: Consultant/Advisory Board (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing)
Monday, February 27, 2023
7:40 AM – 7:55 AM ET
Disclosure(s): Abbott Vascular: Consultant/Advisory Board (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Terminated); Merck Pharmaceuticals: Consultant/Advisory Board (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing)
Monday, February 27, 2023
10:46 AM – 10:54 AM ET
Disclosure information not submitted.
Monday, February 27, 2023
4:45 PM – 4:53 PM ET
Disclosure(s): Abbott Vascular: Consultant/Advisory Board (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Terminated); Merck Pharmaceuticals: Consultant/Advisory Board (Ongoing); Pfizer: Consultant/Advisory Board (Ongoing)